Diamond Biofund Inc. (6901.TW)
TWD 21.65
(-4.2%)
TWD 21.65
(-4.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.24 Million | 1.01 Billion | - | - | - |
| Cost of Revenue | 9.85 Million | - | - | - | - |
| Gross Profit | -7.6 Million | 1.01 Billion | - | - | - |
| Operating Expenses | 152.38 Million | 137.58 Million | 102.42 Million | 404.63 Million | 64.45 Million |
| Selling, General and Administrative Expenses | 152.38 Million | 137.58 Million | 102.42 Million | 404.63 Million | 64.45 Million |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | 2.46 Million | -260 Thousand | -4.87 Million | -2.28 Million |
| Cost and Expenses | 162.23 Million | 137.58 Million | 102.42 Million | 404.63 Million | 64.45 Million |
| Operating Income | -162.23 Million | 881.36 Million | 2.96 Billion | 6.09 Billion | -367.78 Million |
| Interest Expense | 806 Thousand | 245 Thousand | 552 Thousand | 663 Thousand | - |
| Income Tax Expense | -412 Thousand | 83.34 Million | 108.97 Million | 25.19 Million | 110 Thousand |
| Earnings before Tax | -2.58 Billion | 881.12 Million | 2.96 Billion | 6.11 Billion | -370.75 Million |
| Net Income | -2.58 Billion | 797.78 Million | 2.85 Billion | 6.08 Billion | -370.86 Million |
| Earnings Per Share Basic | -3.32 | 1.07 | 3.01 | 6.19 | -0.55 |
| Earnings Per Share Diluted | -3.32 | 1.03 | 2.98 | 6.10 | -0.55 |
| Weighted Average Shares Outstanding | 778.9 Million | 749.3 Million | 948.71 Million | 983.23 Million | 674.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 778.9 Million | 773.21 Million | 954.86 Million | 998.5 Million | 674.37 Million |
| Gross Margin | -3.39 | 1.00 | - | - | - |
| EBIT Margin | -1155.03 | 0.88 | - | - | - |
| Profit Margin | -1151.25 | 0.79 | - | - | - |
| EBITDA | -2.59 Billion | 892.83 Million | 2.97 Billion | 6.12 Billion | -53.89 Million |
| Earnings Before Tax Margin | -72.30 | 0.87 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 7.43 Million | - | 4.68 Million | - | - | - |
| Gross Profit | -7.43 Million | - | -4.68 Million | - | - | - |
| Operating Expenses | 42.97 Million | 39.36 Million | 33.71 Million | 55.49 Million | 33.4 Million | 34.92 Million |
| Selling, General and Administrative Expenses | 42.97 Million | 39.36 Million | 33.71 Million | 55.49 Million | 33.4 Million | 34.92 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 467 Thousand | 662 Thousand | - | 684 Thousand | 642 Thousand | 584 Thousand |
| Cost and Expenses | 42.97 Million | 39.36 Million | 38.4 Million | 55.49 Million | 33.4 Million | 34.92 Million |
| Operating Income | -133.1 Million | -806.28 Million | -38.4 Million | -1.31 Billion | -1.43 Billion | -27.03 Million |
| Interest Expense | 963 Thousand | 965 Thousand | 797 Thousand | - | 1000.00 | 8000.00 |
| Income Tax Expense | - | - | 230.59 Million | - | -412 Thousand | - |
| Earnings before Tax | -134.06 Million | -807.25 Million | 191.39 Million | -1.31 Billion | -1.43 Billion | -27.04 Million |
| Net Income | -134.06 Million | -807.25 Million | 191.39 Million | -1.31 Billion | -1.43 Billion | -27.04 Million |
| Earnings Per Share Basic | -0.16 | -0.95 | 0.23 | -1.71 | -1.92 | -0.04 |
| Earnings Per Share Diluted | -0.16 | -0.95 | 0.23 | -1.71 | -1.92 | -0.04 |
| Weighted Average Shares Outstanding | 837.91 Million | 849.99 Million | 849.89 Million | 766.19 Million | 750.59 Million | 749.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 837.91 Million | 849.99 Million | 849.89 Million | 766.19 Million | 750.59 Million | 749.3 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -125.67 Million | -800.34 Million | 196.88 Million | -1.3 Billion | -1.43 Billion | -24.13 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NITO
MRKS
9300
VIVXF
HG
3684